Items where authors include "Catto, J.W.F."

Article

Griffin, J. orcid.org/0000-0003-3969-7637, Down, J., Quayle, L.A. et al. (10 more authors) (2024) Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial. The Journal of Pathology: Clinical Research, 10 (2). e12363. ISSN 2056-4538

Rogers, Z., Glaser, A., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (17 more authors) (2023) Health‐related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year. BJU International. ISSN 1464-4096

Rogers, Z., Glaser, A., Catto, J.W.F. et al. (17 more authors) (2023) Quality of life after a diagnosis of Bladder Cancer: Longitudinal survey over the first year. BJU International. ISSN 1464-4096

Nanton, V. orcid.org/0000-0002-9553-822X, Bryan, R.T. orcid.org/0000-0003-2853-4293, Pope, A.M. et al. (11 more authors) (2023) Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action. BMJ Oncology, 2 (1). e000092. ISSN 2752-7948

Catto, J.W.F. orcid.org/0000-0003-2787-8828, North, B., Goff, M. et al. (6 more authors) (2023) Protocol for the YORKSURe prospective multistage study testing the feasibility for early detection of bladder cancer in populations with high disease-specific mortality risk. BMJ Open, 13 (9). e076612. ISSN 2044-6055

Conroy, S. orcid.org/0000-0001-7167-4908, Catto, J.W.F. orcid.org/0000-0003-2787-8828, Bex, A. et al. (11 more authors) (2023) Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019. BJU International. ISSN 1464-4096

Jubber, I. orcid.org/0000-0002-4558-2521, Morhardt, D.R., Griffin, J. orcid.org/0000-0003-3969-7637 et al. (10 more authors) (2023) Analysis of the distal urinary tract in larval and adult zebrafish reveals homology to the human system. Disease Models & Mechanisms, 16 (7). dmm050110. ISSN 1754-8403

Dixon, S., Hill, H. orcid.org/0000-0002-0908-5595, Flight, L. et al. (47 more authors) (2023) Cost-effectiveness of robot-assisted radical cystectomy vs open radical cystectomy for patients with bladder cancer. JAMA Network Open, 6 (6). e2317255. ISSN 2574-3805

Mandrik, O. orcid.org/0000-0003-3755-3031, Hahn, A.I., Catto, J.W.F. et al. (3 more authors) (2023) Critical appraisal of decision models used for the economic evaluation of bladder cancer screening and diagnosis: a systematic review. PharmacoEconomics, 41 (6). pp. 633-650. ISSN 1170-7690

Cooper, O.A.E., Ghatnekar, O., Piglowska, N. et al. (5 more authors) (2023) Elicitation of health state utilities associated with progression from Bacillus Calmette-Guerin (BCG) unresponsive Non-muscle Invasive Bladder Cancer (NMIBC). PharmacoEconomics - Open, 7 (3). pp. 469-477. ISSN 2509-4262

Bryant, R.J. orcid.org/0000-0002-8330-9251, Yamamoto, H. orcid.org/0000-0003-0831-9174, Eddy, B. et al. (26 more authors) (2023) Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique. BJU International. ISSN 1464-4096

Catto, J.W.F. orcid.org/0000-0003-2787-8828, Mandrik, O. orcid.org/0000-0003-3755-3031, Quayle, L.A. et al. (12 more authors) (2023) Diagnosis, treatment and survival from bladder, upper urinary tract and urethral cancers: real-world findings from NHS England between 2013 and 2019. BJU International. ISSN 1464-4096

Conroy, S., Pang, K., Jubber, I. et al. (5 more authors) (2022) Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients. BJUI Compass. ISSN 2688-4526

Lane, J.A., Donovan, J.L., Young, G.J. et al. (26 more authors) (2022) Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). BJU International, 130 (3). pp. 370-380. ISSN 1464-4096

Jubber, I., Rogers, Z., Catto, J.W.F. et al. (4 more authors) (2022) Sexual activity, function and dysfunction after a diagnosis of bladder cancer. The Journal of Sexual Medicine, 19 (9). pp. 1431-1441. ISSN 1743-6095

Conroy, S., Hubbard, R., Noon, A.P. et al. (4 more authors) (2022) Case of the month from the University of Sheffield, UK : expediting definitive treatment in patients with invasive bladder cancer : an MRI-guided pathway. BJU International, 129 (6). pp. 691-694. ISSN 1464-4096

Griffin, J. orcid.org/0000-0003-3969-7637, Chen, Y., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (1 more author) (2022) Gene of the month: NKX3.1. Journal of Clinical Pathology, 75 (6). pp. 361-364. ISSN 0021-9746

Hussain, S.A. orcid.org/0000-0003-1552-511X, Lester, J.F., Jackson, R. et al. (17 more authors) (2022) Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE) : a double-blind, randomised, phase 2 trial. The Lancet Oncology, 23 (5). pp. 650-658. ISSN 1470-2045

Galesloot, T.E., Grotenhuis, A.J., Kolev, D. et al. (16 more authors) (2022) Genome-wide meta-analysis identifies novel genes associated with recurrence and progression in non–muscle-invasive bladder cancer. European Urology Oncology, 5 (1). pp. 70-83. ISSN 2588-9311

Tan, W.S., Leow, J.J., Marchese, M. et al. (10 more authors) (2021) Defining factors associated with high-quality surgery following radical cystectomy : analysis of the British Association of Urological Surgeons cystectomy audit. European Urology Open Science, 33. pp. 1-10. ISSN 2666-1683

Tamhankar, A.S., Thurtle, D., Hampson, A. et al. (7 more authors) (2021) Radical cystectomy in England from 2013 to 2019 on 12,644 patients : an analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data. BJUI Compass, 2 (5). pp. 338-347.

Shariat, S., Gontero, P. and Catto, J.W.F. orcid.org/0000-0003-2787-8828 (2021) How to treat a patient with T1 high-grade disease and no tumour on repeat transurethral resection of the bladder? European Urology Oncology, 4 (4). pp. 663-669. ISSN 2588-9311

Catto, J.W.F. orcid.org/0000-0003-2787-8828, Downing, A., Mason, S. et al. (9 more authors) (2021) Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes. European Urology, 79 (5). pp. 621-632. ISSN 0302-2838

Crabb, S.J., Danson, S. orcid.org/0000-0002-3593-2890, Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (16 more authors) (2021) Phase I trial of DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine for solid malignancies including urothelial carcinoma (SPIRE). Clinical Cancer Research, 27 (7). pp. 1882-1892. ISSN 1078-0432

Catto, J.W.F. orcid.org/0000-0003-2787-8828, Gordon, K., Collinson, M. et al. (14 more authors) (2021) Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study. Journal of Clinical Oncology, 39 (3). pp. 202-214. ISSN 0732-183X

Del Giudice, F.D., Pecoraro, M., Vargas, H.A. et al. (8 more authors) (2020) Systematic review and meta-analysis of vesical imaging-reporting and data system (VI-RADS) inter-observer reliability : an added value for muscle invasive bladder cancer detection. Cancers, 12 (10). 2994.

Noble, S.M., Garfield, K., Lane, J.A. et al. (24 more authors) (2020) The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer. British Journal of Cancer, 123 (7). pp. 1063-1070. ISSN 0007-0920

Ürün, Y., Hussain, S.A. orcid.org/0000-0003-1552-511X, Bakouny, Z. et al. (13 more authors) (2020) Survey of the impact of COVID-19 on oncologists’ decision making in cancer. Jco Global Oncology, 6. pp. 1248-1257. ISSN 2687-8941

Leow, J.J., Catto, J.W.F. orcid.org/0000-0003-2787-8828, Efstathiou, J.A. et al. (8 more authors) (2020) Quality indicators for bladder cancer services : a collaborative review. European Urology, 78 (1). pp. 43-59. ISSN 0302-2838

Mostafid, A.H., Porta, N., Cresswell, J. et al. (14 more authors) (2020) CALIBER - A phase II randomised feasibility trial of chemoablation with mitomycin versus surgical management in low risk non-muscle invasive bladder cancer. BJU International, 125 (6). pp. 817-826. ISSN 1464-4096

Birtle, A., Johnson, M., Chester, J. et al. (21 more authors) (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. The Lancet, 395 (10232). pp. 1268-1277. ISSN 0140-6736

Williams, S.B., Ray-Zack, M.D., Hudgins, H.K. et al. (7 more authors) (2019) Impact of centralizing care for genitourinary malignancies to high-volume providers: a systematic review. European Urology Oncology, 2 (3). pp. 265-273. ISSN 2588-9311

McNeill, R.V., Mason, A.S., Hodson, M.E. et al. (2 more authors) (2019) Specificity of the metallothionein-1 response by cadmium-exposed normal human urothelial cells. International Journal of Molecular Sciences, 20 (6). 1344. ISSN 1661-6596

Downing, A., Wright, P., Hounsome, L. et al. (23 more authors) (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncology, 20 (3). pp. 436-447. ISSN 1470-2045

Mason, S.J. orcid.org/0000-0003-0306-8353, Catto, J.W.F. orcid.org/0000-0003-2787-8828, Downing, A. et al. (3 more authors) (2018) Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. BJU International , 122 (5). pp. 760-773. ISSN 1464-4096

Donnelly, D.W., Donnelly, C., Kearney, T. et al. (26 more authors) (2018) Urinary, bowel and sexual health in older men from Northern Ireland. BJU International, 122 (5). pp. 845-857. ISSN 1464-4096

Cumberbatch, M.G.K., Jubber, I., Black, P.C. et al. (9 more authors) (2018) Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018. European Urology. ISSN 0302-2838

Panebianco, V., Narumi, Y., Altun, E. et al. (15 more authors) (2018) Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). European Urology, 74 (3). pp. 294-306.

Catto, J.W.F., Khetrapal, P., Ambler, G. et al. (12 more authors) (2018) Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study. BMJ Open, 8 (8). e020500.

Cumberbatch, M.G.K., Foerster, B., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (6 more authors) (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. European Urology, 73 (6). pp. 925-933. ISSN 0302-2838

Melling, G.E., Flannery, S.E., Abidin, S.A. et al. (13 more authors) (2018) A miRNA-145/TGF-β1 Negative Feedback Loop Regulates the Cancer-Associated Fibroblast Phenotype. Carcinogenesis, 39 (6). pp. 798-807. ISSN 0143-3334

Obajemu, O., Mahfouf, M. and Catto, J.W.F. (2018) A new fuzzy modeling framework for integrated risk prognosis and therapy of bladder cancer patients. IEEE Transactions on Fuzzy Systems, 26 (3). pp. 1565-1577. ISSN 1063-6706

Crabb, S., Danson, S.J., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (12 more authors) (2018) SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial. Trials, 19. 216. ISSN 1745-6215

Pang, K.H., Groves, R., Venugopal, S. et al. (2 more authors) (2018) Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. European Urology, 73 (3). pp. 363-371. ISSN 0302-2838

Cumberbatch, M.G. and Catto, J.W.F. orcid.org/0000-0003-2787-8828 (2018) Re: Comprehensive Molecular Characterization of Muscle Invasive Bladder Cancer. European Urology, 73 (3). pp. 479-480. ISSN 0302-2838

Oughton, J.B. orcid.org/0000-0002-2047-804X, Poad, H., Twiddy, M. et al. (14 more authors) (2017) Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study. BMJ Open, 7 (8). e017913.

MacLennan, S.J., MacLennan, S., Bex, A. et al. (10 more authors) (2017) Changing current practice in urology: Improving guideline development and implementation through stakeholder engagement. European Urology, 72 (2). pp. 161-163. ISSN 0302-2838

Catto, J.W.F. orcid.org/0000-0003-2787-8828 (2017) Speeding up recovery from radical cystectomy: how low can we go? BJU International , 120 (2). pp. 162-163. ISSN 1464-4096

Catto, J.W.F. orcid.org/0000-0003-2787-8828, Blazeby, J.M., Holmberg, L. et al. (2 more authors) (2017) In Defense of Randomized Clinical Trials in Surgery: Let Us Not Forget Archie Cochrane's Legacy. European Urology, 71 (5). pp. 820-821. ISSN 0302-2838

Pang, K.H., Rosario, D.J., Morgan, S.L. et al. (1 more author) (2017) Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies. PLoS One, 12 (4). e0175070.

Edmondson, A.J., Birtwistle, J.C., Catto, J.W.F. et al. (1 more author) (2017) The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence. Journal of Cancer Survivorship. ISSN 1932-2259

Bryan, R.T., Evans, T., Dunn, J.A. et al. (6 more authors) (2015) A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer. European Urology Focus, 1 (1). 82 - 89.

Boström, P.J., Bjartell, A.S., Catto, J.W.F. et al. (6 more authors) (2015) Genomic Predictors of Outcome in Prostate Cancer. European Urology, 68 (6). pp. 1033-1044. ISSN 0302-2838

Yuh, B., Wilson, T., Bochner, B. et al. (9 more authors) (2015) Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. European Urology, 67 (3). 402 - 422. ISSN 0302-2838

Novara, G., Catto, J.W.F., Wilson, T. et al. (9 more authors) (2015) Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. European Urology, 67 (3). 376 - 401. ISSN 0302-2838

Drayton, R.M., Rehman, I., Clarke, R. et al. (13 more authors) (2015) Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA. Cancer Epidemiology, Biomarkers and Prevention, 24 (1). 268 - 275. ISSN 1055-9965

Borkowska, E.M., Kruk, A., Jedrzejczyk, A. et al. (11 more authors) (2014) Molecular subtyping of bladder cancer using Kohonen self-organizing maps. Cancer Medicine, 3 (5). pp. 1225-1234.

Wang, W.T., Catto, J.W.F. and Meuth, M. (2014) Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors. Oncogene, 34 (22). 2887 - 2896. ISSN 0950-9232

Drayton, R.M., Peter, S., Myers, K. et al. (4 more authors) (2014) MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer. Oncotarget, 5 (15). pp. 6375-6386.

Drayton, R.M., Dudziec, E., Peter, S. et al. (4 more authors) (2014) Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11. Clinical Cancer Research, 20 (7). pp. 1990-2000. ISSN 1078-0432

Noon, A.P., Albertsen, P.C., Thomas, F. et al. (2 more authors) (2013) Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. British Journal of Cancer , 108 (7). pp. 1534-1540. ISSN 0007-0920

Miah, S., Dudziec, E., Drayton, R.M. et al. (5 more authors) (2012) An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. British Journal of Cancer, 107 (1). pp. 123-128. ISSN 0007-0920

Bryant, R.J., Pawlowski, T., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (6 more authors) (2012) Changes in circulating microRNA levels associated with prostate cancer. British Journal of Cancer, 106 (4). pp. 768-774. ISSN 0007-0920

Catto, J.W.F., Abbod, M.F., Wild, P.J. et al. (10 more authors) (2010) The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression. European Urology, 57 (3). pp. 398-406. ISSN 0302-2838

Rehman, I., Cross, S.S. orcid.org/0000-0003-2044-1754, Azzouzi, A.R. et al. (7 more authors) (2004) S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. British Journal of Cancer, 91. pp. 739-744. ISSN 0007-0920

Calvert, N.W., Morgan, A.B., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (4 more authors) (2003) Effectiveness and cost-effectiveness of prognostic markers in prostate cancer. British Journal of Cancer, 88. pp. 31-35. ISSN 0007-0920